Ductal carcinoma in situ: how should we treat it?

Author： Bayraktar Soley   Arun Banu   Glück Stefan  

Publisher： Future Medicine

ISSN： 1758-1923

Source： Breast Cancer Management, Vol.2, Iss.3, 2013-05, pp. : 245-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ?

By Rakovitch Eileen  

Breast Cancer Research and Treatment, Vol. 87, Iss. 3, 2004-10 ,pp. : 265-272

Springer Publishing Company

Access to resources Recommend Favorite

Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

By Persiani Roberto  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1077-1079

Springer Publishing Company

Access to resources Recommend Favorite

How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide

By McKay Andrew  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite

Epidemiology of Ductal Carcinoma In Situ

By Kerlikowske Karla  

Journal of the National Cancer Institute Monographs, Vol. 2010, Iss. 41, 2010-10 ,pp. : 139-141

Oxford University Press

Access to resources Recommend Favorite

Dissemination research in cancer control: where are we and where should we go?

By Bowen Deborah  

Cancer Causes and Control, Vol. 20, Iss. 4, 2009-05 ,pp. : 473-485

Springer Publishing Company

Access to resources Recommend Favorite